A shareholder's lawsuit accused Silicon Valley consumer healthcare company Theranos of buying outside lab equipment through a shell company, misrepresenting the health of the company's finances, and running fake tests.
Theranos countered that the accusations represented a "one-sided filing by one party to litigation" and that it would fight the allegations in court rather than respond to the accusations now.
Hedge fund Partner Fund sued Theranos in October, saying that the company misled the fund when it solicited $96 million in funding in 2014.
(What will move markets this quarter and how should investors position themselves ahead of time? Jim Cramer sat down with four of TheStreet's top columnists recently to get their views. Click here to listen to his latest Trading Strategies roundtable with them and read their advice for stocks, bonds, forex and gold.)